Skip to content

Steroid-Skreen 35061703

by Biochemical Diagnostics Inc

Steroid-Skreen 35061703, a medical device (FDA Class I; FDA product code CCY, Zimmerman (Spectrophotometric), 17-Ketosteroids) made by Biochemical Diagnostics Inc, was listed in FDA GUDID on 8 May 2020 (UDI-DI 00810042681897); the registry lists it as not in commercial distribution (GUDID) as of 22 Oct 2026.

Listed FDA GUDID listing, not in commercial distribution

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00810042681897 UDI-DI Date8 May 2020ListedStatusListed GUDID: not in commercial distribution

Official records

From the FDA record

Device description
SODIUM HYDROXIDE, 3N, 2.65L
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Steroid-Skreen
Generic name
17-Ketosteroid (17KS) IVD, reagent
Model / Ref / Catalog
35061703
Primary DI / UDI-DI
00810042681897
FDA product code
CCY
GMDN term
17-Ketosteroid (17KS) IVD, reagent
Device class
Class I
Regulation number
862.1430
GUDID distribution status
Not in Commercial Distribution

Other devices from Biochemical Diagnostics Inc

See all devices from Biochemical Diagnostics Inc →

Properties

  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)